| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2025 | Jul 24, 2025 | CARLSMED, INC. | Director | Buy | 100.0 | +483,999 | 100.00% | ✗ | $7M |
| Mar 3, 2021 | Mar 18, 2022 | ARS Pharmaceuticals, Inc. | Director | Buy | 56.3 | +2,364 | 0.10% | ✗ | $36K |
| Mar 30, 2021 | Mar 31, 2021 | Edgewise Therapeutics, Inc. | Director | Buy | 97.5 | +15,625 | 100.00% | ✗ | $250K |
| Dec 8, 2020 | Dec 8, 2020 | ARS Pharmaceuticals, Inc. | Director | Buy | 100.0 | +95,238 | 100.00% | ✗ | $2M |
| Jun 6, 2012 | Jun 7, 2012 | AtriCure, Inc. | 10% Owner | Sell | 26.3 | -357,617 | -15.87% | ✗ | $47.6K |